238 related articles for article (PubMed ID: 16621188)
21. The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization.
Shi SQ; Peng JP; Li YC; Qin C; Liang GD; Xu L; Yang Y; Wang JL; Sun QH
Mol Immunol; 2006 Apr; 43(11):1791-8. PubMed ID: 16423399
[TBL] [Abstract][Full Text] [Related]
22. Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection.
Fan YY; Huang ZT; Li L; Wu MH; Yu T; Koup RA; Bailer RT; Wu CY
Arch Virol; 2009; 154(7):1093-9. PubMed ID: 19526193
[TBL] [Abstract][Full Text] [Related]
23. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
Zhi Y; Kobinger GP; Jordan H; Suchma K; Weiss SR; Shen H; Schumer G; Gao G; Boyer JL; Crystal RG; Wilson JM
Virology; 2005 Apr; 335(1):34-45. PubMed ID: 15823604
[TBL] [Abstract][Full Text] [Related]
24. Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.
Dutta NK; Mazumdar K; Lee BH; Baek MW; Kim DJ; Na YR; Park SH; Lee HK; Kariwa H; Mai le Q; Park JH
Immunol Lett; 2008 Jun; 118(1):65-71. PubMed ID: 18440652
[TBL] [Abstract][Full Text] [Related]
25. Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization.
Kong WP; Xu L; Stadler K; Ulmer JB; Abrignani S; Rappuoli R; Nabel GJ
J Virol; 2005 Nov; 79(22):13915-23. PubMed ID: 16254327
[TBL] [Abstract][Full Text] [Related]
26. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
[TBL] [Abstract][Full Text] [Related]
27. Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates.
Liu SJ; Leng CH; Lien SP; Chi HY; Huang CY; Lin CL; Lian WC; Chen CJ; Hsieh SL; Chong P
Vaccine; 2006 Apr; 24(16):3100-8. PubMed ID: 16494977
[TBL] [Abstract][Full Text] [Related]
28. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes.
Liu J; Sun Y; Qi J; Chu F; Wu H; Gao F; Li T; Yan J; Gao GF
J Infect Dis; 2010 Oct; 202(8):1171-80. PubMed ID: 20831383
[TBL] [Abstract][Full Text] [Related]
29. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
30. TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).
Jayakumar A; Castilho TM; Park E; Goldsmith-Pestana K; Blackwell JM; McMahon-Pratt D
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1204. PubMed ID: 21695103
[TBL] [Abstract][Full Text] [Related]
31. Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice.
Wang Z; Yuan Z; Matsumoto M; Hengge UR; Chang YF
Biochem Biophys Res Commun; 2005 Feb; 327(1):130-5. PubMed ID: 15629440
[TBL] [Abstract][Full Text] [Related]
32. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
Kim TW; Lee JH; Hung CF; Peng S; Roden R; Wang MC; Viscidi R; Tsai YC; He L; Chen PJ; Boyd DA; Wu TC
J Virol; 2004 May; 78(9):4638-45. PubMed ID: 15078946
[TBL] [Abstract][Full Text] [Related]
33. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
[TBL] [Abstract][Full Text] [Related]
34. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.
Woo PC; Lau SK; Tsoi HW; Chen ZW; Wong BH; Zhang L; Chan JK; Wong LP; He W; Ma C; Chan KH; Ho DD; Yuen KY
Vaccine; 2005 Oct; 23(42):4959-68. PubMed ID: 15993989
[TBL] [Abstract][Full Text] [Related]
35. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.
Lu B; Huang Y; Huang L; Li B; Zheng Z; Chen Z; Chen J; Hu Q; Wang H
Immunology; 2010 Jun; 130(2):254-61. PubMed ID: 20406307
[TBL] [Abstract][Full Text] [Related]
36. Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope.
Cheung YK; Cheng SC; Sin FW; Chan KT; Xie Y
Vaccine; 2007 Aug; 25(32):6070-7. PubMed ID: 17629360
[TBL] [Abstract][Full Text] [Related]
37. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.
Iwata-Yoshikawa N; Uda A; Suzuki T; Tsunetsugu-Yokota Y; Sato Y; Morikawa S; Tashiro M; Sata T; Hasegawa H; Nagata N
J Virol; 2014 Aug; 88(15):8597-614. PubMed ID: 24850731
[TBL] [Abstract][Full Text] [Related]
38. SARS Immunity and Vaccination.
Zhu M
Cell Mol Immunol; 2004 Jun; 1(3):193-8. PubMed ID: 16219167
[TBL] [Abstract][Full Text] [Related]
39. Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice.
Hu H; Tao L; Wang Y; Chen L; Yang J; Wang H
Biotechnol Lett; 2009 Nov; 31(11):1685-93. PubMed ID: 19579009
[TBL] [Abstract][Full Text] [Related]
40. Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus.
Ba L; Yi CE; Zhang L; Ho DD; Chen Z
Appl Microbiol Biotechnol; 2007 Oct; 76(5):1131-6. PubMed ID: 17581748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
